Retinalamin by Geropharm is a retina-specific peptide bioregulator: a complex of low-molecular-weight peptides selected to support the metabolism of retinal cells. It is the targeted ophthalmology product in the line of tissue-specific peptide preparations (together with Cortexin for the brain).
Composition
How it works
Retinal peptides act as tissue-specific signals: they support protein synthesis and metabolic activity in retinal pigment epithelium and photoreceptor cells. The principle is the same as Cortexin for cerebral tissue - restoring the "working program" of a specific cell type under degenerative or ischemic stress.
Where Retinalamin is used
Administration
Product features
Contraindications
Hypersensitivity to components. Pregnancy and breastfeeding - only under medical supervision. Parabulbar administration is performed only by an ophthalmologist.
FAQ
Yes - same manufacturer and same tissue-specific peptide principle, but different targets: Cortexin is standardized to cerebral cortex peptides, Retinalamin to retina peptides. For combined neuro-ophthalmic protocols physicians sometimes use both; each is chosen for its target tissue.
Parabulbar delivers the peptides closer to the target tissue; intramuscular is simpler and more comfortable. Both are validated routes - the choice depends on the ophthalmologist's protocol.
The standard IM course is 10 days (one vial daily where 5 mg dosing is prescribed, or 2 vials per the 10 mg protocol - per physician). Retinal courses are typically repeated 1-2 times per year.
Yes - one of its documented applications is progressive myopia-related retinal changes in pediatric ophthalmology, under specialist supervision.
No - it is a systemic (IM) or near-eye (parabulbar) metabolic support, complementary to local ophthalmic therapy. It does not substitute anti-VEGF intravitreal injections and similar treatments.
Ask a question or inquire about delivery to your country

